Abstracts tagged "axial spondyloarthritis and back pain"

Abstract Number: 572 • 2019 ACR/ARP Annual Meeting
Early Recognition of Patients with Axial Spondyloarthritis by Using a Practical Referral System – Evaluation of the Recently Proposed 2-step Strategy
Xenofon Baraliakos¹, Styliani Tsiami ², doris morzeck ², Kirill Fedorov ², Uta Kiltz ² and Jürgen Braun ³, ¹Rheumazentrum Ruhrgebiet-Ruhr-University Bochum, Herne, Germany, Herne, Germany, ²Rheumazentrum Ruhrgebiet/Ruhr University Bochum, Herne, Germany, Herne, Germany, ³Rheumazentrum Ruhrgebiet/Ruhr University, Herne, Germany
Background/Purpose: Early recognition of axial spondyloarthritis (axSpA) in primary care (PC) is difficult due to the high prevalence of low back pain resulting in a…
Abstract Number: 594 • 2017 ACR/ARHP Annual Meeting
Imaging Biomarkers in Crohn’s Associated Axial Spondyloarthritis
Fardina Malik¹, John A. Carrino², Madeline Epsten³, Ellen Scherl⁴, Stephanie Wichuk⁵, Ulrich Weber⁶, Susanne J Pedersen⁷, Joel Paschke⁸, Jackie Szymonifka³, Georg Kroeber⁹, Randy Longman⁴, Walter P. Maksymowych⁵ and Lisa A. Mandl³, ¹Rheumatology, Hospital For Special Surgery, New York, NY, ²Radiology, Hospital for Special Surgery, New York, NY, ³Rheumatology, Hospital for Special Surgery, New York, NY, ⁴Gastroenterology, Weill Cornell Medical College, New York, NY, ⁵Medicine, University of Alberta, Edmonton, AB, Canada, ⁶Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark, ⁷Copenhagen Center for Arthritis Research, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark, ⁸CARE Arthritis, Edmonton, AB, Canada, ⁹University of Southern Denmark, Odense, Denmark
Background/Purpose: Axial SpA has been reported in 4-16% of patients with Crohn's disease (CD). However, some plain radiograph or magnetic resonance imaging (MRI) studies in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].